NTBL Notable Labs Inc.: יחס שווי שוק לערך בספרים
Notable Labs, Ltd. (NTBL) combines AI-driven live-cell screening with an express biosample delivery system, creating a B2B partnership with pharma behemoths. The market cap to book value ratio on GURU.Markets visualizes this synergy, where the current parameter equals 0.33. However, success depends on the platform's implementation in clinics and strict control of R&D expenses amid limited capital reserves.
%20-%20%D7%99%D7%97%D7%A1%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_NTBL_-_Notable-Labs-Ltd._-_Market-Cap-to-Net-Assets-Ratio "NTBL יחס שווי שוק לערך בספרים Notable Labs Inc. (21.02.2024 - 02.11.2024) | 👁️GURU.Markets👁️")
NTBL (Notable Labs Ltd): פילוחים אנליטיים ודוחות לפי אינדיקטורים
Notable Labs, Ltd. (NTBL) is developing an AI platform for the personalization of oncology therapies, leveraging venture capital. This price-to-book ratio reflects the premium or discount of the business value relative to its net assets. The metric is calculated by dividing the current market capitalization by the equity. A decline in this indicator below industry averages signals a "value trap" risk. For a startup, this serves as a tool to balance speculative optimism against the actual value of its resources.